Covaxx announces Covid-19 vaccine purchase deals worth $2.8bn
US company COVAXX has announced $2.8bn advanced purchase commitments of over 140 million doses of its UB-612 vaccine to be…

US company COVAXX has announced $2.8bn advanced purchase commitments of over 140 million doses of its UB-612 vaccine to be…
Thank you for subscribing to Pharmaceutical Technology